DE:ENM's free cash flow for Q was $-4.27M. For the fiscal year, DE:ENM's free cash flow was decreased by $15.78M and operating cash flow was $-843.00K. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ -14.56M	$ -21.09M	$ -26.84M	$ -25.89M	$ -23.24M	$ -28.58M
Investing Cash Flow	$ 14.71M	$ 31.16M	$ -20.69M	$ -20.72M	$ -28.06M	$ -21.77M
Financing Cash Flow	$ -5.27M	$ -3.27M	$ 29.64M	$ 47.15M	$ 22.05M	$ 92.27M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 96.74M	$ 47.11M	$ 38.70M	$ 57.06M	$ 53.62M	$ 84.20M
Income Tax Paid Supplemental Data	-	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Interest Paid Supplemental Data	$ 62.00K	$ 62.00K	$ 42.00K	$ 0.00	$ 30.00K	$ 0.00
Issuance Of Capital Stock	-	-	$ 32.50M	$ 45.10M	$ 182.00K	$ 87.99M
Issuance Of Debt	$ -2.00M	-	$ 709.00K	$ 1.25M	$ 0.00	$ 258.00K
Repayment Of Debt	$ -4.00M	$ -4.00M	$ -1.55M	$ 0.00	$ -1.50M	$ 0.00
Free Cash Flow	$ -26.70M	$ -26.56M	$ -42.34M	$ -45.21M	$ -37.26M	$ -50.36M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

CASI Pharmaceuticals Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing